Aseptic/Sterile Processing

INCOG Biopharma Completes Construction of Cleanroom Production Area

April 07, 2022

INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility.

Considering Blow-Fill-Seal for Biologic Drugs

April 02, 2022

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

G-CON’s standardPOD Cleanrooms Available in Europe

March 08, 2022

G-CON’s signature standardPOD cleanrooms will now be available in Europe.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

February 23, 2022

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.

New Isolator for Cell and Gene Therapy Manufacturing

December 13, 2021

SKAN’s new Cellana isolator is designed for GMP manufacturing of ATMPs.

Fareva and ApiJect Plan Vaccine Packaging Capacity in France

December 13, 2021

Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.

Looking Back at 2021 Pharma Manufacturing Topics

December 13, 2021

New processes, automation, and digitalization were highlighted in 2021.

Trends in Isolator Equipment

December 03, 2021

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

December 02, 2021

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 5

November 19, 2021

Jordi Serrat, Product & Technology Director, Azbil Telstar talks about the role of disruptive and digital technologies in aseptic processing.